Ricevi le ultime notizie sulle azioni Cibus con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di CBUS

Ultime notizie per

CIBUS INC

Cibus

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Cibus Inc

News

Financing

Press Releases

Cibus, Inc. Announces Closing of $27.5 Million Public Offering

Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming

General

The U.S. Food and Drug Administration Completes Review of Cibus' Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed

Cibus Announces Steps to Implement More Streamlined Business Focus on its Nearest Term Revenue Opportunities

Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call

Earnings

Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025

Contracts

Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance Trait

Health Care

Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025

Penny Stocks

Management

Cibus Announces the Election of Kimberly A. Box to Board of Directors

Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola

CBUS

MGRC

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

aTyr Pharma

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Clene

Connect Biopharma Holdings Limited - Ordinary Shares

Connect Biopharma Hldgs

Fortress Biotech

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

InflaRx

Immix Biopharma

Immunic

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

OKYO Pharma

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Pelthos Therapeutics

Quince Therapeutics

Repare Therapeutics

Spruce Biosciences

Shattuck Labs

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Comments

Cibus Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO